Enterprise Value to EBITDA Multiple ratio Analysis of Cardio Diagnostics HLDG WT - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY EV to EBITDA
Period Ending - Dec-23

-0.0014


Very Poor EV to EBITDA
Period Ending - Dec-22
0.605

Excellent EV to EBITDA
Growth
-100.24 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23

0


Very Poor EV to EBITDA
EV to EBITDA Analysis of Cardio Diagnostics HLDG WT
EV to EBITDA Ratio of CDIOW drastically fell by -100.24 % this year.
Other EV to EBITDA Related Info of CDIOW that may interest you.
Cardio Diagnostics HLDG WT Overview
CodePricePrevious PricePrice ChangeSector
CDIOW0.05510.07 21.29 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued.    more ..
Enterprise Value to EBITDA Multiple  Formula

EV to EBITDA Related Ratios
EBITDAMarginEVToRevenuePriceToEarningRatio

Tsr Value Index
Poor Value Stock
FY - Historical Enterprise Value to EBITDA Multiple of Cardio Diagnostics HLDG WT
PeriodDec-23Dec-22Dec-21Dec-20
EV to EBITDA-0.00140.605-0.0190-0.480
Change-100.24 %3283.64 %96.04 %
FY Chart of Enterprise Value to EBITDA Multiple of Cardio Diagnostics HLDG WT


Note : All Data Generated at the End of Trading Hours (EOD Data)